MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/dddt.s609835

Медицинская библиотека · Drug design, development and therapy · 2026

Effects of Remimazolam Dose and Bolus Injection Rate on Hiccups During Painless Colonoscopy: A Double-Blind Randomized Clinical Trial.

Lu Yanping, Wang Xuewei, Zou Henjing, Shao Changhui, Lai Guangyi, Ou Shan

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Remimazolam is increasingly used for procedural sedation because of its rapid onset, rapid recovery and favourable haemodynamic profile. However, hiccups remain a clinically relevant adverse event that may interfere with endoscopic manipulation. The independent and combined effects of remimazolam dose and injection rate on hiccup occurrence have not been well characterized.

METHODS

In this prospective, randomized, double-blind, 2×2 factorial trial, adult patients undergoing painless colonoscopy were randomized to receive remimazolam at 0.3 or 0.4 mg kg-1, administered over 10s or 20s. The primary endpoint was hiccup incidence. Secondary endpoints included body movement, supplemental bolus requirements, time to loss of eyelash reflex, recovery time, haemodynamic changes, Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scores and postoperative Numeric Rating Scale (NRS) scores. Multivariable logistic regression evaluated the independent effects of dose and injection rate on hiccup incidence and tested for interaction.

RESULTS

Both the higher remimazolam dose (0.4 mg kg-1) and the slower bolus injection rate (20s) were independently associated with a lower incidence of hiccups. After adjustment for age, sex, body mass index, smoking status, hypertension and diabetes, the 0.4 mg kg-1 regimen showed lower odds of hiccups than the 0.3 mg kg-1 regimen, and 20s administration showed lower odds than 10s. No significant dose × rate interaction was detected. The higher-dose regimen was additionally associated with fewer body movements and supplemental boluses, without increased haemodynamic compromise.

CONCLUSION

Both a higher remimazolam dose and a slower bolus injection rate were independently associated with a lower incidence of hiccups during painless colonoscopy. Remimazolam 0.4 mg kg-1 administered over 20s may offer the most favourable balance between hiccup prevention, procedural conditions and haemodynamic stability.

Для цитирования: Lu Yanping, Wang Xuewei, Zou Henjing, Shao Changhui, Lai Guangyi, Ou Shan. Effects of Remimazolam Dose and Bolus Injection Rate on Hiccups During Painless Colonoscopy: A Double-Blind Randomized Clinical Trial.. Drug design, development and therapy. 2026. DOI: 10.2147/dddt.s609835.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.